Latest Breaking News On - Terns pharmaceuticals inc - Page 1 : comparemela.com

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Terns pharmaceuticals inc

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkMiami beachLoews miami beach hotelMarriott marquisCompany nasdaqGoldman sachsTerns pharmaceuticalsBerry company public relationsTerns pharmaceuticals incUpcoming june investorFireside chatAnnual global healthcare conference

Decheng Capital LLC Takes $4 64 Million Position in Terns Pharmaceuticals, Inc (NASDAQ:TERN)

Decheng Capital LLC Takes $4 64 Million Position in Terns Pharmaceuticals, Inc (NASDAQ:TERN)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Exchange commissionSecurities exchange commissionQuarter for terns pharmaceuticalsVivo opportunity llcRussell investments group ltdNews ratings for terns pharmaceuticals dailyTerns pharmaceuticals trading downDecheng capitalFranklin resources incTerns pharmaceuticals incAffinity asset advisorsTerns pharmaceuticalsFree reportAsset advisorsInvestments groupVivo opportunity

Terns Pharmaceuticals, Inc (NASDAQ:TERN) Receives $14 94 Consensus PT from Brokerages

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month price objective […]

Affinity asset advisorsTerns pharmaceuticalsTerns pharmaceuticals price performanceAnalyst recommendations for terns pharmaceuticalsTerns pharmaceuticals company profileVivo opportunity llcNews ratings for terns pharmaceuticals dailyInsider activity at terns pharmaceuticalsTerns pharmaceuticals incGet free reportVivo opportunityFire capitalAsset advisorsGet freeTerns pharmaceuticals daily

Terns Pharmaceuticals, Inc (NASDAQ:TERN) Receives Average Rating of Moderate Buy from Analysts

Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) have earned an average rating of “Moderate Buy” from the eight research firms that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month […]

Vivo opportunity llcTerns pharmaceuticals incAffinity asset advisorsTerns pharmaceuticals stock performanceNews ratings for terns pharmaceuticals dailyAnalyst recommendations for terns pharmaceuticalsTerns pharmaceuticalsInsider transactions at terns pharmaceuticalsGet free reportVivo opportunityFire capitalAsset advisorsGet freeTerns pharmaceuticals daily